Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition
The ISME Journal · 08.01.2024 · 18 (1)
DOI: 10.1093/ismejo/wrad028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 10.01.2024. Verfasst von Li Song und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, College of Natural Resources and Environment, Northwest A&F Universit…. Hauptthemen laut MEDLINE: Bacterial Proteins, Type VI Secretion Systems. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The type VI secretion system (T6SS) is a bacterial weapon capable of delivering antibacterial effectors to kill competing cells for interference competition, as well as secreting metal ion scavenging effectors to acquire essential micronutrients for exploitation competition. However, no T6SS effectors that can mediate both interference competition and exploitation competition have been reported. In this study, we identified a unique T6SS-1 effector in Yersinia pseudotuberculosis named TepC, which plays versatile roles in microbial communities. First, secreted TepC acts as a proteinaceous siderophore that binds to iron and mediates exploitative competition. Additionally, we discovered that TepC has DNase activity, which gives it both contact-dependent and contact-independent interference competition abilities. In conditions where iron is limited, the iron-loaded TepC is taken up by target cells expressing the outer membrane receptor TdsR. For kin cells encoding the cognate immunity protein TipC, TepC facilitates iron acquisition, and its toxic effects are neutralized. On the other hand, nonkin cells lacking TipC are enticed to uptake TepC and are killed by its DNase activity. Therefore, we have uncovered a T6SS effector, TepC, that functions like a “Trojan horse” by binding to iron ions to provide a valuable resource to kin cells, whereas punishing cheaters that do not produce public goods. This lure-to-kill mechanism, mediated by a bifunctional T6SS effector, may offer new insights into the molecular mechanisms that maintain stability in microbial communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, College of Natural Resources and Environment, Northwest A&F University, Yangling, Shaanxi 712100, China.
- Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, Shaanxi 712100, China.
- College of Plant Protection, Northwest A&F University, Yangling, Shaanxi 712100, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Song, L., Xu, L., Wu, T., Shi, Z., Kareem, H. A., Wang, Z., Dai, Q., Guo, C., Pan, J., Yang, M., Wei, X., Wang, Y., Wei, G., & Shen, X. (2024). Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition. The ISME Journal, 18(1). https://doi.org/10.1093/ismejo/wrad028
Vancouver
Song L, Xu L, Wu T, Shi Z, Kareem HA, Wang Z, et al. Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition. The ISME Journal. 2024;18(1). doi:10.1093/ismejo/wrad028
BibTeX
@article{Song2024,
author = {Song, Li and Xu, Lei and Wu, Tong and Shi, Zhenkun and Kareem, Hafiz Abdul and Wang, Zhuo and Dai, Qingyun and Guo, Chenghao and Pan, Junfeng and Yang, Mingming and Wei, Xiaomeng and Wang, Yao and Wei, Gehong and Shen, Xihui},
title = {Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition},
journal = {The ISME Journal},
year = {2024},
volume = {18},
number = {1},
doi = {10.1093/ismejo/wrad028}
}
EUVIMED